Daptomycin-Induced Posterior Reversible Encephalopathy Syndrome (PRES)

AIMS: To present a 60-year-old female patient who manifested clinical and radiological features of posterior reversible encephalopathy syndrome (PRES) following the administration of Daptomycin for glycopeptide-resistant Enterococcal urinary tract infection. MATERIAL: Case report. METHOD: Posterior reversible encephalopathy syndrome was diagnosed in our patient following the administration of Daptomycin based on clinical suspicion as well as brain CT and MRI imaging. RESULTS: The temporal association between the initiation of Daptomycin and the onset of PRES is highly suggestive of causality, and this is further supported by clinical and radiological resolution after Daptomycin was withdrawn. CONCLUSION: This is the first report of Daptomycin-induced posterior reversible encephalopathy syndrome.